Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab)

Reagent Code: #139982

blur_circular Chemical Specifications

inventory_2 Storage & Handling
Storage -20℃

description Product Description

Used in the treatment of autoimmune diseases such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by neutralizing interleukin-17A, a key cytokine involved in inflammatory pathways, thereby reducing inflammation and disease symptoms. Commonly administered via subcutaneous injection, it helps improve skin clearance, joint function, and quality of life in affected patients.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 50μg
10-20 days ฿4,980.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab)
No image available
Used in the treatment of autoimmune diseases such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by neutralizing interleukin-17A, a key cytokine involved in inflammatory pathways, thereby reducing inflammation and disease symptoms. Commonly administered via subcutaneous injection, it helps improve skin clearance, joint function, and quality of life in affected patients.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...